FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066526 [Registered on: 30/04/2024] Trial Registered Prospectively
Last Modified On: 29/04/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A clinical trial to study the efficacy of individualized homoeopathic medicine in patients with chronic and acute type of pain.  
Scientific Title of Study   Efficacy of individualized homoeopathic medicines in pain management an open-label study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Md Mirajul Haque 
Designation  UG Student (3rd B.H.M.S.) 
Affiliation  Metropolitan Homoeopathic Medical College And Hospital 
Address  OPD of department of gynecology and obstetrics of Metropolitan Homoeopathic Medical College and Hospital. Ramchandrapur road ,sodepur kolkata 700110
OPD of department of gynecology and obstetrics of Metropolitan Homoeopathic Medical College and Hospital. Ramchandrapur road ,sodepur kolkata 700110
North Twentyfour Parganas
WEST BENGAL
700110
India 
Phone  6294186241  
Fax    
Email  haquemirajul7467@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Md. Mirajul Haque 
Designation  UG Student (3rd B.H.M.S) 
Affiliation  Metropolitan Homoeopathic Medical College And Hospital 
Address  OPD of department of gynecology and obstetrics of Metropolitan Homoeopayhic Medical College and Hospital. Ramchandrapur road,sodepur kolkata 700110
OPD of department of gynecology and obstetrics of Metropolitan Homoeopayhic Medical College and Hospital. Ramchandrapur road,sodepur kolkata 700110
North Twentyfour Parganas
WEST BENGAL
700110
India 
Phone  6294186241  
Fax    
Email  haquemirajul7467@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Chandra Nath Das 
Designation  Principal 
Affiliation  Metropolitan Homoeopathic Medical College And Hospital 
Address  Principal room at Metyropoloitan Homoeopathic Medical College and Hospital. Ramchandrapur road,sodedpur kolkata 700110

North Twentyfour Parganas
WEST BENGAL
700110
India 
Phone  03325955326  
Fax    
Email  mhmch1@gmail.com  
 
Source of Monetary or Material Support  
Metropolitan Homoeopathic Medical College and Hospital. Ramchandrapur,Sodepur,kolkata-700110 
 
Primary Sponsor  
Name  Metropolitan Homoeopathic Medical College And Hospital 
Address  Ramchandrapur Road,Sodepur, Kolkata-700110 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Asit Bhowmick  Metropliton Homoeopathic Medical College and Hospital   Ramchandrapur Road sodeur kolkata700110,OPD& DEPARTMENT OF GYNECOLOGY AND OBSTETRICS DEPARTMENT
North Twentyfour Parganas
WEST BENGAL 
8240826264

asitbhowmick900@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R52||Pain, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic Medicine  Individualized Homoeopathic medicine in the basis of totality of symptoms .We observe the efficacy of individualized homoeopathic medicine on 1week of intervention 3 times in a month.Dose is based on susceptibility of the patients and orally adminustered and total duration of intervention is 6 months. 
Comparator Agent  Not applicable   Not applicable  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients suffering from acute or chronic type of pain. 2.Patients willing to participate in the study and giving written consent of it. 
 
ExclusionCriteria 
Details  1.Patients who are too unwell to take part 2.Self reported immune response person. 3.Substances abuse or /and independence. 4.individuals experiencing cyclic or intermittent pain such as those with condition like Mygraines,Dysmennorhoea,Cluster headaches,Endometriosis,Irritable bowel movementor other Episiodic pain disorders are excluded from this study. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Mcgill pain questionnaire-It is used for evaluate a person expriencing significant pain.it is used monitor the pain over time and to determine the effectiveness of individualized Homoeopathic Medicine upto 1 months of 3 times intervention in every week.  1Month. 
 
Secondary Outcome  
Outcome  TimePoints 
Euroqol 5d 5l-It is a visual analog scale.The descriptive system comprises of 5 dimension.This scale used for evaluate the severity of pain expriencing by some individual.It analyze the efficacy of Individualized Homoeopathic Medicine upto 1 month of intervention 3 times in every weak timeperiod.  1Month 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [haquemirajul7467@gmail.com].

  6. For how long will this data be available start date provided 30-07-2024 and end date provided 30-08-2024?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   In single blind ,non- randomized, single arms trial ,30  patients will receive individualized homoeopathic medicine. Patient administered for severe pain both acute and chronic type. Severity index will taken as the primary and secondary outcomes respectively, measured at baseline. And observation taken at a 7 days interval up to 3 weeks of treatment 
Close